ACSL4 could activate fatty acids by adding CoA and abnormal expression of ACSL4 was reported in several cancers and may affect prostaglandin biosynthesis, fatty acid β-oxidation, ferroptosis, and phosphatidyl chain remodeling. This evidence concerns the gene ACSL4 and cancer.